Being a comprehensive in nature, Next-Generation Sequencing (NGS) Services market research report gives better insights about different market segments on which businesses are highly depending for thriving in the market. All the information, statistics and data included in this report has been collected from the truthful sources such as websites, newspapers, journals, white papers, mergers, and annual reports of the companies. This report also offers such wide-ranging market information to explore practical growth strategies and recommendations. This information is again tested and verified by the market experts before providing it to the end user.

Data Bridge Market Research analyses that the next-generation sequencing (NGS) services market is expected to undergo a CAGR of 22.00% during the forecast period. This indicates that the market value, which was USD 6,588.68 million in 2021, would rocket up to USD 32,335.31 million by 2029. “Whole-genome Sequencing” dominates the type segment of the next-generation sequencing (NGS) services market owing to increasing number of hospitals and research laboratories in the developing regions and numerous initiatives undertaken by universities, academic and research institutions and research establishments for utilizing this technology in identifying root cause of diseases. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

 

 

 

Next-generation sequencing is a technology that is aggressively being employed by the hospitals and clinics for analysis, testing, and diseases diagnostics. Next-generation sequencing is used in the drug development processes using a wide array of methods.

 

 

 

Surging awareness about the benefits of next generation sequencing is one of the major factors fostering the growth of the market. Some benefits of next generation sequencing technology are low cost and pricing of sequencing technology, high accuracy, high speed and quicker results and precision in the results. 

 

Rising expenditure for research and development proficiencies especially in the developed and developing economies pertaining to the medical instruments and devices will further create lucrative market growth opportunities. Research and development proficiencies being conducted for the integration of advanced technologies in the healthcare facilities and on the detection of infectious diseases is also bolstering the market growth rate.

 

Some of the major players operating in the next-generation sequencing (NGS) services market are Medtronic (Ireland), Ethicon US, LLC. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Novo Nordisk A/S (Denmark), BD (U.S.), Stryker (U.S.), Boston Scientific Corporation (U.S.), Luminex Corporation (US), Eurofins Scientific SE (Luxembourg), PerkinElmer, Inc. (U.S.), QIAGEN (Germany), Macrogen Inc. (South Korea), GENEWIZ, Inc. (U.S.), Illumina, Inc. (U.S.), Novogene Corporation (China), Abcam plc (UK), Merck KGaA (Germany), Promega Corporation (US), Siemens (Germany), and GATC Biotech AG (Germany) among others.

 

 

 

Chapter 1: Next-Generation Sequencing (NGS) Services Market Overview

 

Chapter 1.1: Study Assumptions

 

Chapter 1.2: Scope of the Study

 

Chapter 2: Next-Generation Sequencing (NGS) Services Market Economic Impact

 

Chapter 2.1: Analysis Methodology

 

Chapter 2.2: Research Phases

 

Chapter 3: Competition by Manufacturers

 

Chapter 3.1: Current Market Scenario

 

Chapter 3.2: Value Chain/Supply Chain Analysis

 

Chapter 3.3: Government Regulations and Initiatives

 

Chapter 4: Production, Revenue (Value) by Region

 

Chapter 5: Supply (Production), Consumption, Export, Import by Regions

 

Chapter 5.1: Market Drivers

 

Chapter 5.2: Market Restraints/Challenges

 

Chapter 5.3: Market Opportunities

 

Chapter 6: Production, Revenue (Value), Price Trend by Type

 

Chapter 7: Market Analysis by Application

 

Chapter 8: Market by Manufacturing Cost Analysis

 

Chapter 9: Industrial Chain, Sourcing Strategy and Downstream Buyers

 

Chapter 10: Marketing Strategy Analysis, Distributors/Traders

 

Chapter 11: Market Geographic Analyses

 

Chapter 12: Next-Generation Sequencing (NGS) Services Market Effect Factors Analysis

 

Chapter 13: Next-Generation Sequencing (NGS) Services Market Forecast

 

Chapter 14: Future of the Market

 

Chapter 15: Appendix

 

 

 

 

An absolute way to predict what the future holds is to understand the current trend! Data Bridge Market Research presented itself as an unconventional and neoteric market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are committed to uncovering the best market opportunities and nurturing effective information for your business to thrive in the marketplace. Data Bridge strives to provide appropriate solutions to complex business challenges and initiates an effortless decision-making process. Data Bridge is a set of pure wisdom and experience that was formulated and framed in 2015 in Pune.

 

Data Bridge Market Research has more than 500 analysts working in different industries. We have served more than 40% of the Fortune 500 companies globally and have a network of more than 5,000 clients worldwide. Data Bridge is an expert in creating satisfied customers who trust our services and trust our hard work with certainty. We are pleased with our glorious 99.9% customer satisfaction rating.

 

 

Data Bridge Market Research

 

US: +1 888 387 2818

 

United Kingdom: +44 208 089 1725

 

Hong Kong: +852 8192 7475

 

Email: – sopan.gedam@databridgemarketresearch.com